Keywords: Bayer, Onyx Pharma, Nexavar, Regorafenib, Partnership, Settlement

Bayer settles with Onyx over Nexavar and regorafenib with $160 million payment

Article | 13 October 2011

Print This

US drugmaker Onyx Pharmaceuticals (Nasdaq: ONXX) and German pharma major Bayer HealthCare, a unit of Bayer AG (BAY: DE), have ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in